CLL — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Chronic lymphocytic leukaemia
Marked lymphocytosis with small mature lymphocytes, smear cells, hepatosplenomegaly, lymphadenopathy, and characteristic immunophenotype (CD5+, CD19+, CD23+, CD20dim) is CLL. CLL is the most common leukaemia in adults in Western countries. Staging: Rai (US) or Binet (European). Treatment: observe if asymptomatic (watch and wait). Treat when iwCLL criteria are met (cytopenias, progressive lymphadenopathy/splenomegaly, B symptoms, doubling time <6 months).
Reference: ALLG – 2024 – CLL; iwCLL 2024; NCCN 2025